MY CLINIC
The cost of stem cell therapy for COPD in the Czech Republic typically ranges from $12,000 to $18,000. Prices vary depending on the clinic, the physician’s experience, the number of stem cell infusions, and whether autologous or allogeneic stem cells are used. In the United States, the average cost is $45,000 (per ISSCR data). That means stem cell therapy for COPD in the Czech Republic can be about 67% less than in the U.S.
Czech clinics usually include initial consultation, pre-treatment bloodwork, stem cell harvesting (often from bone marrow or adipose tissue), cell processing, infusion procedures, and follow-up appointments. In the U.S., costs often only cover the infusion, with separate charges for harvesting, lab processing, and post-treatment care. Always check if additional infusions, imaging, or extended follow-up are included in your package.
Why consider the Czech Republic for stem cell therapy for COPD?
Access advanced Stem cell therapy for COPD solutions in trusted clinics .
| Czech Republic | Turkey | Austria | |
| Stem cell therapy for COPD | from $12,000 | from $12,000 | from $32,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell therapy for COPD upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell therapy for COPD and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell therapy for COPD journey.
Stem cell therapy for COPD in the Czech Republic is currently classified as experimental. Patients must weigh the lack of phase-3 clinical evidence against potential procedural risks like infection or pulmonary embolization. Safety depends on strict screening by SAK-accredited facilities and adherence to international research protocols.
Bookimed Expert Insight: Czech clinics like MY CLINIC maintain safety by working with academic institutions like Charles University. Data shows these centers emphasize outpatient safety through SAK accreditation rather than hospital stays. Patients should confirm if a facility uses autologous cells, which naturally reduces immune rejection risks compared to donor cells.
Patient Consensus: Patients emphasize the need to stay on standard inhalers while pursuing experimental care. Traveling for treatment can make it difficult for home doctors to manage long-term monitoring or sudden complications.
Stem cell therapy for COPD is not an approved standard cure in the Czech Republic. The State Institute for Drug Control (SÚKL) and the European Medicines Agency (EMA) classify these treatments as experimental. Medical guidelines prioritize bronchodilators and rehabilitation over regenerative therapies.
Bookimed Expert Insight: While private centers like MY CLINIC in Prague hold SAK accreditation for inpatient safety, they focus on standard diagnostic tools. Most patients seeking stem cell options for lung conditions look toward Turkey or Mexico. These countries handle significantly higher request volumes for these specific experimental protocols.
Patient Consensus: Patients often find clinic marketing confusing and must distinguish between cash-pay treatments and legitimate trials. Pulmonologists suggest focusing on proven symptom management before trying unproven methods that promise tissue reversal.
Stem cell therapy for COPD in the Czech Republic is a regenerative procedure using Mesenchymal Stem Cells (MSCs) to target lung inflammation and tissue damage. Clinics in Prague use autologous cells from the patient's own fat or bone marrow to help repair alveoli and restore pulmonary elasticity.
Bookimed Expert Insight: While many European centers focus solely on IV infusions, Czech clinics like MY CLINIC often leverage ties with academic institutions like Charles University. This ensures patients access protocols aligned with SAK-accredited safety standards, even for experimental regenerative treatments. Costs range from $12,000 to $18,000, providing a significant alternative to US costs.
Patient Consensus: Patients note that while this is not a structural cure, it often results in modest improvements in daily breathing and exercise tolerance. Most recommend asking for specific FEV1 measurements to track progress objectively after the procedure.
Patients traveling to the Czech Republic for COPD stem cell therapy follow a streamlined medical tourism protocol involving remote screening, clinical assessment in Prague, and cell administration. The process typically requires a short 1 to 3 day stay at private facilities like MY CLINIC.
Bookimed Expert Insight: While many clinics offer standard IV infusions, centers in Prague like MY CLINIC focus on high standards through SAK accreditation. This certification ensures safety in inpatient care. Patients should prioritize clinics that share records with academic institutions like Charles University to ensure higher medical oversight during experimental treatments.
Patient Consensus: The experience is often a quick trip rather than a long hospital stay. Travelers suggest bringing a companion and coordinating local follow-up care early, as post-procedure support from abroad is often limited.